-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
Review
(2253) Views (626) Full article downloads
Authors: Robert A Bok
Published Date March 2008
Volume 2008:4(1) Pages 79 - 85
DOI: http://dx.doi.org/10.2147/TCRM.S905
Robert A Bok
Department of Radiology, University of California at San Francisco, San Francisco, CA, USA
Abstract: The body’s immune system has some capacity to recognize and attack cancerous growths, including prostate cancer. However, various intrinsic characteristics of tumor cells usually limit that capacity. Therapeutically administered immunologic stimuli, such as APC8015, an individualized, ex vivo stimulation of a patient’s own antigen presenting cells (APC), are capable of boosting the anti-tumor response. Late phase clinical trials of APC8015 (now also called Sipuleucel-T) show evidence of slowing disease progression and increasing survival in advanced prostate cancer. Such immunotherapeutic approaches hold real promise to provide additional useful and welcome weapons against this common malignancy.
Keywords: prostate cancer, antigen presenting cells, immunologics
Readers of this article also read:
A review of topotecan in combination chemotherapy for advanced cervical cancer
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Trabectedin and its potential in the treatment of soft tissue sarcoma
A review of solifenacin in the treatment of urinary incontinence
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Fluticasone furoate nasal spray in the treatment of allergic rhinitis
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Erratum
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
